Predicted LncRNA

DataTables

LncRNA Compound Cancer P-value Effect
ENSG00000240453.1 ABT-263 (navitoclax) Chronic Lymphocytic Leukemia 0.024879982 Resistant
ENSG00000240453.1 ABT-263 (navitoclax) Sarcoma 0.032679626 Sensitive